Terug
Dagbereik
€ 94,24
€ 97,79
52-Weeksbereik
€ 55,54
€ 113,02
Volume
483.457
50D / 200D Gem.
€ 102,59
/
€ 91,47
Vorige Slotkoers
€ 94,77
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -16,6 | 0,4 |
| P/B | 5,7 | 2,9 |
| ROE % | -36,7 | 3,8 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 137,44
+42.5%
Low: € 120,00
High: € 155,00
Forward WPA
-€ 5,56
Omzet Sch.
14 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 6,16
€ 1,30 – € 12,24
|
1,3 B | 5 |
| FY2029 |
€ 3,26
€ 0,69 – € 6,48
|
930 M | 10 |
| FY2028 |
-€ 0,93
-€ 4,47 – € 2,94
|
530 M | 12 |
Belangrijkste Punten
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -275,21M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-36,70%
ROIC-24,89%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,00
Current Ratio15,27
Interest Coverage0,00
Waardering
P/E Ratio
-16,59
P/B Ratio5,65
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -425,38M |
| ROE | -36,70% | ROA | -30,11% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -275,21M |
| ROIC | -24,89% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 15,27 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -16,59 | P/B Ratio | 5,65 |
| P/S Ratio | N/A | PEG Ratio | -0,35 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 7,06B | Enterprise Value | 6,80B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -425,38M | -260,76M | -126,22M | -81,85M | -46,34M |
| EPS (Diluted) | -5,85 | -3,93 | -2,17 | -1,65 | -2,13 |
| Gross Profit | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -414,31M | -280,37M | -149,49M | -86,11M | -45,82M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,41B | 1,14B | 732,38M | 482,46M | 293,82M |
| Total Liabilities | 164,37M | 71,96M | 31,82M | 19,48M | 8,79M |
| Shareholders' Equity | 1,25B | 1,07B | 700,56M | 462,98M | 285,04M |
| Total Debt | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Cash & Equivalents | 261,75M | 145,69M | 335,39M | 241,81M | 68,53M |
| Current Assets | 1,39B | 1,13B | 726,49M | 477,99M | 290,63M |
| Current Liabilities | 91,17M | 54,02M | 31,82M | 19,48M | 8,79M |